Neurocrine Biosciences, Inc. (NBIX): Price and Financial Metrics
NBIX Price/Volume Stats
| Current price | $101.74 | 52-week high | $157.98 |
| Prev. close | $100.68 | 52-week low | $84.23 |
| Day low | $100.83 | Volume | 1,588,200 |
| Day high | $102.68 | Avg. volume | 1,440,160 |
| 50-day MA | $109.13 | Dividend yield | N/A |
| 200-day MA | $126.71 | Market Cap | 10.07B |
NBIX Stock Price Chart Interactive Chart >
Neurocrine Biosciences, Inc. (NBIX) Company Bio
Neurocrine Biosciences discovers and develops pharmaceuticals for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company was founded in 1992 and is based in San Diego, California.
NBIX Price Returns
| 1-mo | -11.99% |
| 3-mo | -31.06% |
| 6-mo | -12.35% |
| 1-year | -27.38% |
| 3-year | 8.67% |
| 5-year | 3.63% |
| YTD | -25.47% |
| 2024 | 3.60% |
| 2023 | 10.31% |
| 2022 | 40.24% |
| 2021 | -11.14% |
| 2020 | -10.83% |
Continue Researching NBIX
Want to do more research on Neurocrine Biosciences Inc's stock and its price? Try the links below:Neurocrine Biosciences Inc (NBIX) Stock Price | Nasdaq
Neurocrine Biosciences Inc (NBIX) Stock Quote, History and News - Yahoo Finance
Neurocrine Biosciences Inc (NBIX) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...